Skip to content

Clinical trials

Phase 2 Diabetes Mellitus trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 2 Country / region: Russia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20075
20092
20111
20152

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S2
Akros Pharma Inc.1
Bristol-Myers Squibb1
Eli Lilly and Company1
GlaxoSmithKline1
Ionis Pharmaceuticals, Inc.1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Novartis Pharmaceuticals1
Takeda1
Wyeth is now a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus11
Diabetes Mellitus, Type 29
Body Weight1
Diabetes Mellitus, Lipoatrophic1
Diabetes Mellitus, Type 11
Diabetic Nephropathies1
Dyslipidemias1
Endocrine System Diseases1
Glucose Metabolism Disorders1
Hyperglycemia1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.